Cornerstone Planning Group’s Bio-Techne TECH Stock Holding History

Cornerstone Planning Group’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.65K	Sell	23 -64	-74%	-$3.46K	﹤0.01%	1373
2026 Q1	$4.88K	Buy	87 +12	+16%	+$720	﹤0.01%	1091
2025 Q4	$4.92K	Sell	75 -27	-26%	-$1.64K	﹤0.01%	992
2025 Q3	$788	Buy	102 +22	+28%	+$1.18K	﹤0.01%	1369
2025 Q2	$4.37K	Buy	80 +62	+344%	+$3.12K	﹤0.01%	756
2025 Q1	$903	Sell	18 -12	-40%	-$813	﹤0.01%	1162
2024 Q4	$2.29K	Buy	30 +26	+650%	+$1.91K	﹤0.01%	761
2024 Q3	$283	Sell	4 -10	-71%	-$751	﹤0.01%	1209
2024 Q2	$1.09K	Buy	+14	New	+$1.03K	﹤0.01%	917
2022 Q4	$1.62K	Buy	+20	New	+$1.59K	﹤0.01%	1246

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Cornerstone Planning Group's TECH Position: Q2 2026 in Review

Cornerstone Planning Group reduced its Bio-Techne (TECH) stake by 74% in Q2 2026, selling an estimated $3.46K and leaving 23 shares worth $1.65K. The position accounts for ﹤0.01% of the portfolio, ranked #1373.

Cornerstone Planning Group first reported a position in TECH in Q4 2022 and has held it in 10 quarters since. The position peaked at $4.92K in Q4 2025. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Cornerstone Planning Group held 23 shares of Bio-Techne worth $1.65K as of Q2 2026.
Cornerstone Planning Group sold 64 Bio-Techne shares in Q2 2026, an estimated $3.46K.
Bio-Techne made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #1373 holding.
Cornerstone Planning Group first reported a position in Bio-Techne in Q4 2022 and has held it in 10 quarters since.
Cornerstone Planning Group's Bio-Techne position peaked at $4.92K in Q4 2025.
596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.